GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Novolog (pharm-up 1966) Ltd (XTAE:NVLG) » Definitions » COGS-to-Revenue

Novolog (pharm-up 1966) (XTAE:NVLG) COGS-to-Revenue : 0.90 (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Novolog (pharm-up 1966) COGS-to-Revenue?

Novolog (pharm-up 1966)'s Cost of Goods Sold for the three months ended in Sep. 2024 was ₪421 Mil. Its Revenue for the three months ended in Sep. 2024 was ₪466 Mil.

Novolog (pharm-up 1966)'s COGS to Revenue for the three months ended in Sep. 2024 was 0.90.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Novolog (pharm-up 1966)'s Gross Margin % for the three months ended in Sep. 2024 was 9.53%.


Novolog (pharm-up 1966) COGS-to-Revenue Historical Data

The historical data trend for Novolog (pharm-up 1966)'s COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novolog (pharm-up 1966) COGS-to-Revenue Chart

Novolog (pharm-up 1966) Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only 0.90 0.89 0.88 0.88 0.90

Novolog (pharm-up 1966) Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.91 0.90 0.89 0.90 0.90

Novolog (pharm-up 1966) COGS-to-Revenue Calculation

Novolog (pharm-up 1966)'s COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=1474.323 / 1643.489
=0.90

Novolog (pharm-up 1966)'s COGS to Revenue for the quarter that ended in Sep. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=421.305 / 465.706
=0.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novolog (pharm-up 1966)  (XTAE:NVLG) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Novolog (pharm-up 1966)'s Gross Margin % for the three months ended in Sep. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 421.305 / 465.706
=9.53 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Novolog (pharm-up 1966) COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Novolog (pharm-up 1966)'s COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Novolog (pharm-up 1966) Business Description

Traded in Other Exchanges
N/A
Address
Me'ayan 55, near Modi'in, PO Box 377, Modiin, ISR, 71713
Novolog (pharm-up 1966) Ltd is an Israeli public health care company. The company operates in four divisions: The digital division, Health Division, The logistics division and International health services.

Novolog (pharm-up 1966) Headlines

No Headlines